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Abstract: Purpose: Redo cardiac operations represent one of the main challenges in heart surgery. The purpose of the study was to analyze the 
predictors of in-hospital mortality in patients undergoing reoperative cardiac surgery by a single surgical team. Methods: A total of 1367 patients 
underwent cardiac surgical procedures and prospectively entered into a computerized database. Patients were divided into 2 groups based on 
the reoperative cardiac surgery (n = 109) and control group (n = 1258). Uni- and multivariate logistic regression analysis were performed to 
evaluate the possible predictors of hospital mortality. Results: Mean age was 56 ± 13, and 46% were female in redo group. In-hospital mortality 
was 4.6 vs. 2.2%, p = 0.11. EuroSCORE (6 vs. 3; p < 0.01), cardiopulmonary bypass time (90 vs. 71 min; p < 0.01), postoperative bleeding (450 
vs. 350 ml; p < 0.01), postoperative atrial fi brillation (AF) (29 vs. 16%; p < 0.01), and inotropic support (58 vs. 31%; p = 0.001) were signifi cantly 
diff erent. These variables were entered into uni- and multivariate regression analysis. Postoperative AF (OR 1.76, p = 0.007) and EuroSCORE 
(OR 1.42, p < 0.01) were signifi cant risk factors predicting hospital mortality. Conclusions: Reoperative cardiac surgery can be performed under 
similar risks as primary operations. Postoperative AF and EuroSCORE are predictors of in-hospital mortality for redo cases.
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Introduction
Having increased operative and technical skills and 
improved long-term survival after cardiac surgery, 
in recent years, surgeons inclined to perform redo 
cardiac surgery instead of medical therapy or other 
cardiac interventions [1, 2]. Patients with previous 
coronary artery bypass surgery (CABG) tend to have 
more complex disease (high SYNTAX scores), and 
morbidity is signifi cantly higher with percutaneous 
coronary interventions [3]. Even incomplete revas-
cularization is not associated with adverse events 
during follow-up after CABG [4]. Moreover, redo 
CABG is nearly as safe as the primary operation [5]. 
Redo surgery is inevitable in patients with prosthetic 
heart valves that carry similar morbidity and mortal-
ity compared to primary replacement [6]. However, 
mortality seems as much higher as main surgery [7]. 
Therefore, we intended to report the surgical out-
come and determine the predictors that could infl u-
ence or help in the decision to off er medical vs. surgi-
cal therapy.
Patients and Methods
In a retrospective design, we have collected the data of 
1367 consecutive patients who underwent open heart 
surgery between 2010 and 2014. Clinical information 
was stored prospectively in a computerized database. 
All patients were operated by the same surgical team in 
a single center. Of 1367 patients, 109 had redo cardiac 
surgery. The rest of the population comprised the con-
trol group (n = 1258).
Exclusion criteria
Patients were excluded from this analysis if they 1) re-
quired cardiopulmonary resuscitation before opera-
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tion, 2) underwent an acute aortic dissection surgery, 
or 3) underwent thoracic and aortic aneurysm surgical 
procedures.
Preoperative evaluation
For all patients scheduled for redo cardiac surgery, we 
instituted preoperative evaluation of atherosclerosis of 
the ascending aorta, the aortic arch, and the descend-
ing aorta. In patients older than 70 years, this assess-
ment was done by using computed tomography (CT). 
In those younger than 70 years, CT was only done if 
there was carotid bruit, history of stroke, presence of 
diabetes mellitus, peripheral vascular disease or left main 
coronary artery disease, and/or detection of calcifi cation 
in the aortic arch on chest X-ray fi lms. Carotid artery 
Doppler ultrasound was performed in all patients older 
than 60 years of age; in patients with carotid bruit; those 
with a history of stroke; those with diabetes mellitus, 
peripheral vascular disease, or left main coronary artery 
disease; and those with aortic calcifi cation on chest radi-
ography. Cardiac functions were evaluated by using GE/
VingMed Vivid 7 digital transthoracic echocardiography 
(GE Vingmed Ultrasound; GE Vingmed Ultrasound 
AS, Horten, Norway).
Surgical techniques
Three diff erent operative strategies were used to perform 
CABG: 1) cardiopulmonary bypass (CPB) (on-pump) 
with arrested heart (conventional CABG); 2) on-pump 
with beating heart; and 3) off -pump beating heart. The 
decision whether a patient would undergo the proce-
dure on-pump CABG, on-pump with beating heart, or 
off -pump beating heart was made by the same surgeons 
(I.C. and O.G.) according to the severity of coronary 
artery disease, ascending aortic atherosclerosis, and the 
degree of cardiomegaly, and other diseases. For most of 
this series, conventional surgery was the standard strate-
gy. In each of the 1367 subjects, the ascending aorta was 
routinely assessed by intraoperative aortic palpation us-
ing the method described by Mills and Everson [8]. The 
patients with calcifi ed aorta (i.e., unclampable ascending 
aorta) were operated with no-touch aorta technique.
Redo cardiac surgery technique
In 27 cases, the right common femoral artery and the 
right common femoral vein cannulation; in 78 cases, 
aorta–right atrial cannulation; and in 3 cases, axillary 
artery-right femoral vein cannulation were prepared ini-
tially. An oscillating saw was used to divide the sternum. 
Once the posterior table of the sternum was divided 
with the saw, the wires were removed and a sharp dis-
section was done with electrocautery and/or scissors to 
separate each side of the sternum from the underlying 
structures. The dissection plane was close to the sternum 
and developed along the diaphragmatic surface and then 
up around the right atrium towards the aorta. Dissec-
tion on the aorta was performed slowly and diligently to 
avoid penetration and extension beneath the adventitia. 
Dissection of the left heart was completed on CPB. The 
heart was not dissected more than necessary to perform 
the planned operation safely. The patent left internal 
thoracic artery was isolated and controlled either before 
or after the initiation of CPB. In control group, patients 
were cannulated through aorta–right atrium in a stan-
dard manner.
The cardiopulmonary bypass was initiated, and mild 
systemic hypothermia (30–32 °C) was achieved. Ante-
grade blood cardioplegia in induction and continuous 
retrograde blood cardioplegia in maintenance were used 
for myocardial protection.
Statistical Analyses
Statistical analysis was performed using SPSS software 
(Version 17.0, SPSS Inc., Chicago, IL, USA). All nu-
merical data are expressed as mean values ± SD or as 
proportions. Kolmogorov–Smirnov test was used to 
evaluate the normality of data. Continuous variables 
were compared by the use of Student t-test or Mann–
Whitney U depending on parametric and nonparametric 
distribution, respectively. The categorical variables be-
tween the groups were analyzed by using the Chi square 
test or Fisher’s exact test. A univariate analysis was done 
initially, and then, clinical variables that were identifi ed 
as signifi cantly associated with hospital mortality were 
included in a multivariate logistic regression. The odds 
ratio (OR) and 95% confi dence interval (CI) were cal-
culated for each factor in the presence of the others in 
the fi nal model. The level for statistical signifi cance was 
predetermined at p < 0.05.
Results
The mean age of the redo surgery patients was 56 ± 13, 
and 46% (n = 476) were female. Redo cardiac surgery 
was performed in 7.9% (109/1367). Hospital mortal-
ity was 4.6 vs. 2.2% (p = 0.11). CABG (48.6%) was the 
most frequently performed surgery in redo group. Mean 
interval between primary and secondary operations was 
9.7 ± 5.9 years.
Baseline clinical characteristics of the study cohort are 
summarized in Table I. Hypertension (45 vs. 56%; p = 
0.02), median EuroSCORE (6 vs. 3; p < 0.01), preop-
erative atrial fi brillation (AF) (27.5 vs. 6.8%; p < 0.01), 
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and infective endocarditis (5.5 vs. 1%; p = 0.002) were 
signifi cantly diff erent between groups.
Surgical outcomes were summarized in Table II. Me-
dian duration of cardiopulmonary bypass time (90 vs. 
71 min; p < 0.01), length of hospital stay (4 vs. 4 days; 
p = 0.05), and postoperative bleeding (450 vs. 350 mL; 
p < 0.01) were signifi cantly diff erent between groups. 
Postoperative AF (29 vs. 16%; p < 0.01), inotrope sup-
port (58 vs. 31%; p = 0.001), intra-aortic balloon pump 
(IABP) support (2.8 vs. 0.6%; p = 0.03), reexploration 
Table I Baseline clinical characteristics
Redo patients (n = 109) Control group (n = 1258) p
Age (years) 56 ± 13 62 ± 10 <0.01
Female gender 51 (46) 425 (33) 0.005
HTN 48 (45) 705 (56) 0.02
DM 39 (36) 557 (44) 0.07
HL 15 (14) 283 (22) 0.02
Smoking 20 (18) 372 (29) 0.009
COPD 13 (12) 124 (10) 0.29
MI 15 (13) 418 (33) <0.01
Stroke/TIA 8 (7.3) 74 (6) 0.32
PVD 4 (3.4) 59 (4.7) 0.42
Renal failure 6 (5.7) 137 (10.9) 0.05
Infective endocarditis 6 (5.5) 12 (1) 0.002
AF 30 (27.5) 85 (6.8) <0.01
CHF 3 (2.8) 54 (4.3) 0.31
LVEF % 60 (28–60) 62 (20–65) 0.54
 ≤30 6 (5.5) 101 (8)
 30.1–49 23 (21.1) 302 (24.1)
 ≥50 80 (73.4) 852 (67) 0.44
EuroSCORE 6 (1–14) 3 (0–14) <0.01
NYHA class III/IV 44 (40) 408 (32) 0.05
Status 0.54
 Elective 100 (93.5) 1176 (93.6)
 Urgent/emergent 7 (6.5) 81 (6.4)
Current operation <0.01
CABG 53 (48.6) 1119 (88.9)
Aortic valve surgery 32 (29.2) 124 (9.8)
Mitral valve surgery 38 (34.8) 154 (12.2)
Tricuspid valve surgery 17 (15.6) 22 (1.7)
Aortic surgery 8 (7.3) 50 (3.9)
Previous operation
CABG 63 (57.8)
Aortic valve 21 (19.2)
Mitral valve 33 (30.3)
Tricuspid valve 3 (2.7)
Aortic surgery 4 (3.6)
VSD closure 2 (1.8)
Numbers are given as mean ± SD, median (minimum–maximum) or numbers (percentage). LVEF indicates left 
ventricular ejection fraction; CABG, coronary bypass grafting; PVD, peripheral vascular disease; TIA, transient 
ischemic attack; COPD, chronic obstructive pulmonary disease; EuroSCORE, European System for Cardiac Ope-
rative Risk Evaluation; NYHA, New York Heart Association; VSD, ventricular septal defect
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for bleeding (3.7 vs. 0.9%; p = 0.02), and wound infec-
tion (2.8 vs. 0.4%; p = 0.02) were signifi cantly diff erent 
between groups.
In redo cases, 5 (4.6%) patients died due to cardiac 
and multisystemic causes or injury. Mean age and Eu-
roSCORE were 77 and 10.6, respectively, in this group.
Uni- and multivariate analysis
The variables in Tables I and II that were signifi cantly 
diff erent between two groups were entered into uni- 
and multivariate regression analysis. Postoperative AF 
and EuroSCORE exhibited both strong univariate [(OR 
6.46; 95% CI 4.45–9.38, p < 0.01) and (OR 1.46; 95% 
CI 1.40–1.52, p < 0.01), respectively] and multivariate 
associations [(OR 1.76; 95% CI 1.17–2.66, p = 0.007) 
and (OR 1.42; 95% CI 1.36–1.49, p < 0.01), respec-
tively] with hospital mortality (Table III).
Discussion
Cardiac reoperations represent one of the main chal-
lenges in cardiac surgery. The reoperation rate for 
CABG is approximately 3% at 5 years and 11% at 10 
years [2]. The number of patients undergoing reopera-
tion for valvular heart disease is increasing as the gen-
eral population ages [9]. Redo surgery is no longer a 
risk factor for poor outcome and can be done eff ectively 
Table II Postoperative results
Redo patients (n = 109) Control group (n = 1257) p
On-pump with arrested heart 102 (93.6) 1141 (90.7) 0.20
On-pump with beating heart 3 (2.8) 111 (8.8) 0.01
Off-pump with beating heart 4 (3.7) 6 (0.5) 0.006
CPB time (min) 90 (31–294) 71 (17–255) <0.01
Cross clamp time (min) 65 (13–164) 58 (10–168) 0.001
No-touch aortic technique 2 (1.8) 46 (3.7) 0.24
Use of bypass graft
Bypass graft 3 (1–5) 4 (1–6) 0.005
LIMA 28 (52.8) 863 (77) <0.01
SVG 47 (88.6) 833 (74.4) 0.35
Radial artery 4 (7.5) 15 (1.3) 0.006
Mechanical support (hours) 14 (5–89) 14 (3–147) 0.12
ICU length of stay (days) 2 (1–25) 2 (1–27) 0.77
Length of hospital stay (days) 4 (4–25) 4 (3–52) 0.05
Postoperative bleeding (mL) 450 (50–1050) 350 (50–2250) <0.01
Postoperative transfusion (Units)
Packed red blood cells 2 (0–8) 2 (0–10) 0.18
Fresh frozen plasma 5 (0–26) 5 (0–27) 0.16
Postoperative complications
Reexploration for bleeding 4 (3.7) 11 (0.9) 0.02
AF 32 (29) 207 (16) <0.01
Gastrointestinal complication 1 (0.9) 3 (0.2) 0.28
Renal failure 8 (7) 166 (13) 0.06
Pulmoner complication 4 (3.7) 39 (3) 0.45
Stroke/TIA 1 (0.9) 28 (2.2) 0.31
Inotrope support 61 (58) 394 (31) <0.01
IABP support 3 (2.8) 7 (0.6) 0.03
Mediastinitis 0 5 (0.4) 0.66
Wound infection 3 (2.8) 5 (0.4) 0.02
CPB indicates cardiopulmonary bypass; ICU, intensive care unit; IABP, intra-aortic balloon pump; LIMA, left internal 
mammary artery; SVG, saphenous vein graft
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with acceptable risks when specifi c multidisciplinary 
approaches are adopted [10]. In the current era, redo 
CABG is nearly as safe as the primary operation [2]. 
Reoperative surgery even for an elderly patient with 
isolated aortic or mitral valve pathology is associated 
with excellent long-term survival. However, valve re-
operations may have higher risk when patients are not 
referred and operated on early before they develop se-
vere symptoms [5, 11]. Although in-hospital mortality 
seems higher among the elderly than among younger 
patients, redo valvular surgery in an elderly cohort can 
be performed with acceptable morbidity and mortality. 
Expected survival is higher than that without surgical 
intervention. Despite increased resource utilization, 
elderly patients can be off ered redo surgical interven-
tion for valvular heart disease [12]. In this regard, our 
study determined in-hospital mortality after redo sur-
gery is similar to that of primary operation and accords 
with the aforementioned fi ndings. Conversely, unlike 
the previous reports, our study group comprised both 
valvular and CABG reoperations together. Some cases 
underwent both CABG and valve surgery at the same 
time. In such a heterogeneous study group with higher 
EuroSCORE values, we believe that our results diff er 
from other studied patient groups.
Adverse events occur regularly during cardiac reop-
eration and are related to complexity of the procedure. 
Adverse events happen particularly during dissection and 
often when preventive strategies have not been used. 
Compensatory rescue measures are not always success-
ful. Adverse events lead to poor patient outcome and 
higher cost [13]. As anticipated, adverse events aff ecting 
mortality have been developed in the presented study. 
Postoperative AF and high EuroSCORE values were re-
lated to mortality in the study group.
It was reported in a study that advanced NYHA 
functional class was independent predictor of hospital 
mortality in patients submitted for valvular reoperations 
for prosthetic valve dysfunction [14]. In a failing heart, 
IABP represents an option of left ventricular support. 
The need for IABP especially in a high risk valve popula-
tion is associated with early unfavorable outcome [15]. 
On the contrary, our study did not demonstrate a benefi t 
from IABP use.
EuroSCORE accurately predicts short and mid-
term mortality in combined aortic valve replacement 
and coronary artery bypass patients [16]. In high-risk 
patients with complex coronary artery disease (i.e., 
Euro SCORE >5), CABG is superior to other coronary 
re vascularization procedures. AF after cardiac surgery 
occurs in approximately one third of patients and is 
associated with an increase in adverse events and in- 
hospital mortality [17]. Our results determined that AF 
is a predictor of hospital mortality after cardiac reopera-
tions as well.
Limitations
Although all data were collected prospectively, the de-
sign of this study is retrospective. Cases underwent sur-
gery in a single center, and possible selection bias makes 
the results unable to be applied to the general popu-
lation. Furthermore, databases may underreport events 
and risk factors. Therefore, conclusions are necessarily 
limited in their application.
Conclusions
In conclusion, redo cardiac surgery can be performed 
under similar risks as primary operation either CABG, 
aortic, or valve surgery. New onset AF and higher Eu-
roSCORE values predict in-hospital mortality following 
cardiac reoperations.
Table III Uni- and multivariate analysis of clinical variables associated with in-hospital mortality
Univarıate Multivarıate
Variables OR 95% CI p OR 95% CI p
Age 1.04 1.03–1.04 <0.01
Infective endocarditis 6.0 2.2–16.4 0.002
Preoperative AF 3.8 1.6–8.6 0.001
Inotrope support 6.4 2.8–14.3 <0.01
Duration of CPB time 0.9 0.9–0.9 <0.01
Postoperative bleeding 0.9 0.9–1.0 <0.01
IABP support 2.33 0.60–9.02 0.22
EuroSCORE 1.46 1.40–1.52 <0.01 1.42 1.36–1.49 <0.01
Postoperative AF 6.46 4.45–9.38 <0.01 1.76 1.17–2.66 0.007
OR indicates odds ratio; CI, confidence interval; AF, atrial fibrillation
In-hospital mortality and redo cardiac surgery
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